News | Cardiovascular Ultrasound | June 27, 2018

Study results show artificial intelligence-based software has less variability in evaluating left ventricular EF than the reported average variability of cardiologists

EchoMD AutoEF Software Improves Variability in Ejection Fraction Estimation

June 27, 2018 – A recent study conducted with the Minneapolis Heart Institute found that Bay Labs’ EchoMD AutoEF deep learning software has less variability in evaluating left ventricular ejection fraction (EF) than the average variability of cardiologists reported in literature. Results of the study were presented at the 2018 American Society of Echocardiography (ASE) Annual Scientific Sessions, June 22-26 in Nashville.

Literature shows that the average variability of cardiologist readers using the Simpson’s biplane method in estimating EF is 9.2 percent. The observed variability of EchoMD AutoEF was superior at 8.29 percent (p = 0.002). The study also demonstrated that EchoMD AutoEF is an accurate and fully automated method of calculating EF from complete echocardiographic patient studies without user intervention. In addition to normal patients, it performed well on obese patients, and on patients with a range of normal and abnormal EF.

“Historically there have been challenges with variability and reproducibility in reporting of the ejection fraction, especially when the EF is not normal; our study showed that the EchoMD AutoEF algorithms can aid interpretation enormously and have less variability than cardiologists reported in literature,” said Richard Bae, M.D., FACC, director of the Echocardiography Laboratory at the Minneapolis Heart Institute and co-author of the study. “By supporting fast, efficient and accurate AI [artificial intelligence]-assisted echocardiogram analysis, the algorithms can allow physicians to focus on putting results into context for the patient — guiding prognosis and course of management.”

The study included 405 echocardiographic patient studies from Minneapolis Heart Institute representing a wide range of body mass index, EF values and of ultrasound systems. For each patient study, the Bay Labs’ software automatically selected optimal apical four-chamber and apical two-chamber digital video clips and used them to perform an EF calculation. These calculations were compared to the standard Simpson’s biplane method.

For more information: www.baylabs.io


Related Content

News | Radiology Imaging

Feb. 12, 2026 — Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care ...

Time February 13, 2026
arrow
Feature | Cardiac Imaging | Kyle Hardner

Advances in coronary CT angiography (CCTA) have reached the point where image quality and AI capabilities are creating ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 27, 2026 — Hyperfine has announced results from the largest data set to date evaluating stroke detection with its ...

Time January 28, 2026
arrow
News | Radiology Education

Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...

Time January 28, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 27, 2026 — Siemens Healthineers and World Athletics have joined forces to inform medical teams how point-of-care ...

Time January 27, 2026
arrow
News | Radiology Imaging

Jan.26, 2026 — SimonMed Imaging has unveiled an updated brand and the launch of SimonMed Longevity, a new division ...

Time January 27, 2026
arrow
News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
Subscribe Now